Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics

Clinical trial NCT00216684 · COMPLETED

Trial details

NCT number: NCT00216684
Sponsor: Janssen Pharmaceutical K.K.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pain, Intractable

Start date: 2005-05-01
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.